Deskpro Launches New Private Help Desk Solution with Private AI Support for Organizations with Strict Security, Compliance, and Data Sovereignty Requirements
12.11.2025 15:13:00 CET | Business Wire | Press Release
Today, Deskpro, provider of the secure AI-powered help desk platform, announced the launch of Deskpro Private, making AI-powered help desk capabilities available to industries with stringent security and compliance requirements for the first time. The new platform delivers flexible private deployment, allowing companies to run their AI-powered help desk entirely within their AWS Virtual Private Cloud (VPC), on-premise enterprise data center, or sovereign cloud. Enterprises can connect to their AI of choice, including commercial, public, private, custom, and open source models, using existing organizational accounts and APIs. This means sensitive data never leaves the organization’s approved security perimeter. With Deskpro, organizations no longer need to sacrifice the measurable ROI from AI capabilities for data security, compliance, or data sovereignty.
Deskpro Makes Enterprise-Grade AI Support Possible for Compliance-Bound Teams
While many enterprises have experimented and integrated AI capabilities into support operations, organizations in regulated industries and security-conscious enterprises have faced an impossible choice: abandon their compliance requirements to implement AI technology or miss out on AI efficiency gains. According to the State of AI in Support Operations: Balancing Innovation and Compliancereport, which surveyed over 200 IT and support leaders across private and public sectors, on average only 58% of healthcare, government, and education organizations currently use AI, compared to 92% of technology companies, underscoring how privacy and regulatory pressures are slowing adoption in sensitive sectors. Traditional SaaS help desk vendors rely on public cloud infrastructure and centralized AI processing, which presents compliance challenges for organizations that must keep data within specific security perimeters or geographic boundaries.
“The AI revolution has reached help desk platforms, but it’s been remarkably exclusive and available only to those willing to hand over their data to third parties. We’re changing that,” said Brad Murdoch, CEO of Deskpro. “Organizations including banks, healthcare systems, aerospace and defense contractors, and government agencies all understand AI’s value, but have been left behind by the cloud-only approach to AI-powered support tools, prohibiting them from adopting AI without increasing security risks or violating compliance requirements. Deskpro Private eliminates this dilemma entirely. These organizations can finally modernize support operations with AI-powered help desk software that respects the organization’s infrastructure decisions, compliance requirements, and data sovereignty needs.”
Deskpro Private Solves Compliance Dilemma with Unique Combination of AI Capabilities and Deployment Flexibility
Deskpro is a secure omnichannel help desk platform offering seamless management of customer and employee interactions across all channels—email, chat, phone, Slack, Microsoft Teams, social media, and more—within a single, unified solution for consistent and personalized support.
Deskpro Private features AI-powered support tools to deliver measurable productivity gains and faster, more accurate resolutions for customers, including an AI Chatbot for ticket deflection and self-service; AI Agent Assist with copilot-style support; and AI workflows such as sentiment analysis, intent detection, and auto-summarization of multi-thread tickets. These capabilities are now available with complete deployment flexibility across any infrastructure, removing the need for organizations to choose between advanced AI features and infrastructure control.
The State of AI in Support Operations: Balancing Innovation and Compliance report also found that nearly 80% of hybrid support teams are piloting AI, but conversion to production hinges on strong governance, security validation, and enterprise-grade trust. Unlike public cloud-only platforms that require data to flow through public infrastructure, Deskpro Private processes all AI operations within the customer's chosen environment. Organizations can deploy the platform in their existing VPC environment, on-premise data center, or in a sovereign cloud, and securely access their cloud provider’s AI foundation model service (e.g., Amazon Bedrock), while keeping all data, infrastructure, and operations within legal jurisdiction.
“At Deskpro, we envision the help desk evolving from a transactional product into a strategic function, an intelligent nerve center where AI can seamlessly orchestrate requests across every channel and deployment model,” continued Murdoch. “The market is flooded with hype about overnight AI adoption, but the organizations seeing real value are the ones taking time to do it right. That means giving AI access to the right data, integrating it with enterprise systems, and building organizational readiness from the ground up. Deskpro Private empowers enterprises to harness AI on their own terms, with the security, flexibility, and governance required for genuine return on investment.”
Since Deskpro Private is deployed entirely inside an organization’s security perimeter, companies can confidently integrate any and all data across their organization to deliver comprehensive, AI-supported experiences for customers and service agents. With secure access to all relevant data, the platform enables customers to get the answers they need via an AI Chatbot without waiting for human intervention, freeing human agents to focus on solving the more complex problems that require empathy and creativity. This foundational security and resulting efficiency drives a tangible ROI, as improved agent and customer retention directly and measurably boosts company performance.
“IDC’s research indicates security is a high priority for ITSM buyers,” said Snow Tempest, Research Manager, IT Service Management at IDC. “There is a clear market opportunity for vendors who can offer a solution that addresses customer concerns related to regulation, compliance, or data sovereignty requirements.”
Deskpro’s AI of Choice Model Extends Enterprise AI Investments Into the Help Desk
Deskpro customers have the freedom to choose any AI provider to drive the AI features in Deskpro Private, including:
- Commercial and public model providers: OpenAI, Anthropic Claude, Google Gemini, and Mistral AI
- Open source and open weight models: Meta Llama, DeepSeek, and OpenAI
- Custom and private models: LLMs built by enterprises for their internal use
Built for the evolving AI landscape, Deskpro Private offers full support for private AI and a future-ready architecture to support emerging AI providers and other new foundation models as they become available.
Contact Deskpro to schedule a private demonstration of Deskpro Private and discuss how the platform can work within your infrastructure requirements—whether on-premise, in a VPC, or sovereign cloud environment.
Supporting Quotes
“Deskpro has been instrumental in helping us manage our support. The platform’s flexibility and customization capabilities have allowed us to maintain visibility across hundreds of tickets while keeping all our sensitive organizational data secure. Having that level of control over our support infrastructure has been extremely valuable.” – Claduio De Luca, CEO, Serverplan
“Deskpro’s robust feature set, flexible deployment options, and purpose-built migration tool were a game changer for us. We seamlessly migrated all of our data and ticketing history—past and present—and had our customer support operation up and running without missing a beat. In our industry, privacy and security are non-negotiable, and Deskpro’s on-premise solution delivers exactly what we need—and more.”– Ed Fineran, President, Atlantech Online
“Deskpro has been instrumental in helping us manage our support. The platform’s flexibility and customization capabilities have allowed us to maintain visibility across hundreds of tickets while keeping all our sensitive organizational data secure. Having that level of control over our support infrastructure has been extremely valuable. Since implementing Deskpro, we've expanded beyond IT and now have five other departments using the platform to manage their inter-departmental tickets.” – Nicholas Dress, Director IT Service Management, Aurora Mental Health & Recovery
About Deskpro
Deskpro is the developer of AI-driven help desk software that empowers organizations worldwide to deliver exceptional customer and employee experiences that translate directly into tangible ROI, through improved customer and agent retention. Deskpro is the only help desk platform with enterprise-grade security, compliance, and data privacy, enabling all organizations to adopt and deploy AI, even in the most regulated industries and sovereign environments. Deskpro is available as a cloud service, and can also be deployed in VPCs, on-premise, private clouds, and sovereign clouds. Trusted by leading enterprises worldwide in banking, technology, financial services, healthcare systems, aerospace and defense, as well as government agencies, Deskpro is led by experts in enterprise software, customer experience, and customer support. Learn more at Deskpro.com.
Resources
- Deskpro.com
- Download the State of AI in Support Operations: Balancing Innovation and Compliance report
View source version on businesswire.com: https://www.businesswire.com/news/home/20251112219171/en/
Contacts
Media Contact
Stephanie Floyd
Bhava Communications for Deskpro
deskpro@bhavacom.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom